News

Blog News

Sen. Tillis joins NCBIO members for Q&A
News,
Sen. Tillis joins NCBIO members for Q&A

Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North... Continue Reading

Date posted01/14/2022


Who pays to create new medicines?
News,
Who pays to create new medicines?

Who pays to create new medicines? The share of private money invested in developing new medicines approved by the FDA in 2020 exceeded the entire budget of the National Institutes of Health by about 6,500%, according to a new study by Vital Transformation. Vital Transformation... Continue Reading

Date posted01/13/2022


NCBIO forum explores ways to improve recruitment and experience for patients in clinical trials
News,
NCBIO forum explores ways to improve recruitment and experience for patients in clinical trials

Patients and research organizations came together at the NCBIO Clinical Trials Forum to talk about ways to make recruiting and retaining patients easier for clinical trials. The forum was held Wednesday, Dec. 8 at the NC Biotechnology Center. Matthew Roberts, practice group leader, health care... Continue Reading

Date posted01/4/2022


Laura Gunter named to Council of State Bioscience Associations board
News,
Laura Gunter named to Council of State Bioscience Associations board

Laura Gunter, NCBIO president NCBIO President Laura Gunter has been elected to the Board of Directors of the Council of State Bioscience Associations. Gunter will serve a two-year term beginning 2022. “We are thrilled to announce our new slate of incredibly accomplished and esteemed... Continue Reading

Date posted12/9/2021


Laura Gunter: Biotech policies should protect patients, innovation
News,
Laura Gunter: Biotech policies should protect patients, innovation

The ongoing response to the COVID-19 pandemic has highlighted the critical role of the North Carolina life sciences industry in battling our most serious public health threats. When faced with the threat of COVID-19, biotechnology companies — many based right here in North Carolina —... Continue Reading

Date posted12/1/2021


Natacha Janvier joins NCBIO as membership director
News,
Natacha Janvier joins NCBIO as membership director

Natacha Janvier Natacha Janvier has joined NCBIO as the organization's new membership director. Janvier began her new role on Nov. 15. "We are very excited to have Natacha joining us," said NCBIO President Laura Gunter. "She has an impressive background in North Carolina's life sciences... Continue Reading

Date posted12/1/2021


BIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients
News,
BIO: Build Back Better Act weakens U.S. innovation ecosystem, hurts patients

Michelle McMurry-Heath, M.D., Ph.D., president and CEO of the Biotechnology Innovation Organization, released the following statement after the House of Representatives passed the Build Back Better Act on Nov. 19: “The legislation that passed the House today will upend a successful Medicare... Continue Reading

Date posted11/19/2021


NC colleges and universities review workforce training programs with BMF members
News,
NC colleges and universities review workforce training programs with BMF members

Representatives from the NC Community Colleges’ BioNetwork, the NC Pharmaceutical Services Network, BRITE at NC Central University, NC A&T University and North Carolina State University’s BTEC were all on hand Tuesday, Nov. 16, at the NCBIO Biotech Manufacturers Forum Meeting to... Continue Reading

Date posted11/18/2021


Gene therapy pioneer Jude Samulski delivers powerful keynote at NCBIO 2021 Annual Meeting
News,
Gene therapy pioneer Jude Samulski delivers powerful keynote at NCBIO 2021 Annual Meeting

Jude Samulski, Ph.D., told NCBIO Annual Meeting attendees that the field of gene therapy is the beginning of something that will transform lives forever. Therapies created today for rare diseases will tomorrow generate treatments for common ills like high cholesterol, diabetes and heart failure,... Continue Reading

Date posted10/29/2021


Recipients of inaugural Samuel Taylor Life Sciences Scholarships named
News,
Recipients of inaugural Samuel Taylor Life Sciences Scholarships named

NCBIO and the N.C. Community College System announced the recipients of the newly established Samuel M. Taylor Memorial Life Sciences Scholarship. The Samuel M. Taylor Scholarship was established at the North Carolina Community Colleges Foundation Inc. in memory of Sam Taylor, a founder and... Continue Reading

Date posted10/1/2021


BIO’s fall Congressional preview
News,
BIO’s fall Congressional preview

The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry. The State of Play The House adjourned two weeks ago after laying the groundwork (on a party-line... Continue Reading

Date posted09/8/2021


Life Science Caucus focuses on supporting innovative agricultural tech
News,
Life Science Caucus focuses on supporting innovative agricultural tech

Rep. Donna McDowell White welcomes attendees NCBIO President Laura Gunter Scott Uknes, Ph.D., co-founder and co-CEO of AgBiome John Fleming, a farmer and partner with Fleming Brothers Farms, LLC in Halifax Sinnovatek President and CEO Michael Druga T. Y. Baker and... Continue Reading

Date posted09/1/2021